Cybin Inc logo

Cybin Inc

AMEX:CYBN (Canada)   Ordinary Shares
$ 0.36 -0.0054 (-1.5%) 10:09 PM EST
At Loss
P/B:
1.61
Market Cap:
$ 268.93M
Enterprise V:
$ 242.81M
Volume:
2.88M
Avg Vol (2M):
6.46M
Also Trade In:
Volume:
2.88M
At Loss
Avg Vol (2M):
6.46M

Business Description

Description
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.
Name Current Vs Industry Vs History
Cash-To-Debt 106.56
Equity-to-Asset 0.93
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
5-Day RSI 21.35
9-Day RSI 32
14-Day RSI 38.59
6-1 Month Momentum % -13.49
12-1 Month Momentum % 13.73

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.76
Quick Ratio 5.76
Cash Ratio 4.61

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -18.48

Profitability Rank

Name Current Vs Industry Vs History
ROE % -112.24
ROA % -101.33
ROIC % -161.03
ROC (Joel Greenblatt) % -4100.84
ROCE % -107.27